C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia

C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia

Objectives: To explore the negative predictive value (NPV) of C-reactive protein (CRP) at admission to exclude complicated disease manifestations of pneumococcal disease.Methods: A Dutch multicentre retrospective cohort study was conducted between 01-01-2012 and 30-06-2020. Adults with positive bloo...

Full description

Bibliographic Details
Main Authors:	Milou J.V. Serbée, Elisabeth A. Dulfer, Kirsten K.T. Dirkx, Ron Bosboom, Bas Robberts, Heiman F.L. Wertheim, Bert Mulder, Marien I. de Jonge, Carel F. Schaars, Caroline M.A. Swanink, Amelieke J.H. Cremers
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	International Journal of Infectious Diseases
Subjects:	Streptococcus pneumoniae C-reactive protein Invasive pneumococcal disease Empyema
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221006433

Similar Items

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
by: Hafsah D. Tootla, et al.
Published: (2021-04-01)

Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan
by: Jun Yi Sim, et al.
Published: (2020-11-01)

A false‐positive pneumococcal rapid urinary antigen test in Streptococcus intermedius infection
by: Saeko Takahashi, et al.
Published: (2019-10-01)

Outcome of Severe Bacterial Pneumonia in the Era of Pneumococcal Vaccination
by: Teresa del Rosal, et al.
Published: (2020-12-01)

Recurrent pneumococcal bacteraemia in a patient with systemic lupus erythematosus
by: Simon M. Durkin, et al.
Published: (2021-01-01)

The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
by: Kirsten K.T. Dirkx, et al.
Published: (2021-10-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Diagnostic and Management Errors in an Immunodeficient Patient with Pneumococcal Pneumonia with Bacteraemia due to Incorrect Assessment of the Patient’s Immune Status
by: Takahiro Ito, et al.
Published: (2021-04-01)

Vaccination against pneumococcal infections in adults
by: Kozlov R.S., et al.
Published: (2018-02-01)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
by: Catarina Silva-Costa, et al.
Published: (2018-07-01)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2021-01-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

Corticosteroids in Pneumococcal Meningitis
by: J Gordon Millichap
Published: (1991-12-01)

The remaining challenges of pneumococcal disease in adults
by: E. Ludwig, et al.
Published: (2012-03-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
by: Choon How How, et al.
Published: (2016-09-01)

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
by: Stephanie Perniciaro, et al.
Published: (2021-08-01)

Pneumocephalus Associated with Aggressive Pneumococcal Meningitis
by: Isabel I Taveira, et al.
Published: (2020-04-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
by: Sara Tomczyk, et al.
Published: (2018-04-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
by: Nicola Principi, et al.
Published: (2016-12-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
by: Maria Deloria Knoll, et al.
Published: (2021-04-01)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
by: Jacob Dag Berild, et al.
Published: (2020-04-01)

Pneumococcal infections and immunization in diabetic patients
by: V Mohan, et al.
Published: (2011-01-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Pediatric Pneumococcal Serotypes in 4 European Countries
by: Germaine Hanquet, et al.
Published: (2010-09-01)

Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
by: Roger E. Thomas
Published: (2021-02-01)

Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01)

Increased Invasive Pneumococcal Disease, North East England, UK
by: Catherine Houseman, et al.
Published: (2017-01-01)

EFFICACY OF PNEUMOCOCCAL INFECTIONS PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
by: E. V. Galkina-Lazareva
Published: (2012-05-01)

Nasopharyngeal Pneumococcal Colonization among Children after Pneumococcal Conjugate Vaccine Introduction
by: Manoochehr Karami, et al.
Published: (2017-08-01)